Biologic Therapies III
Biologic agents have become an important part of the overall
therapeutic strategies for clinicians caring for patients with
rheumatic and inflammatory diseases. Patients who are
candidates for biologic therapies often present with other comorbidities, including infections, malignancies, cardiovascular disease, and autoimmune diseases. Understanding and incorporating these comorbidities into the management approach is important for clinicians when prescribing biologics in these special populations.
Case-based Lesson |
||
| Patient with Hepatitis B and Rheumatoid Arthritis | ||
| Estimated Time: 30 minutes Release Date: June 5, 2009 Type: Case-Based Lesson |
Technical Requirements: Adobe Reader Expiration Date: June 5, 2011 Specialties: Gastroenterology, Rheumatology |
|
Webcasts |
||
| Autoimmune and Inflammatory Disorders from Bench to Bedside | ||
| Estimated Time: 2 hours 15 minutes Release Date: September 4, 2009 Type: Webcast |
Technical Requirements: Windows Media Expiration Date: September 4, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
| Biologics and Infections: Common and Rare | ||
| Estimated Time: 2 hours 30 minutes Release Date: September 4, 2009 Type: Webcast |
Technical Requirements: Windows Media Expiration Date: September 4, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
| Biologic Therapies The Newer Agents | ||
| Estimated Time: 2 hours 30 minutes Release Date: September 4, 2009 Type: Webcast |
Technical Requirements: Windows Media Expiration Date: September 4, 2011 Specialties: Gastroenterology, Rheumatology / Immunology, Cardiology |
|
| Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents | ||
| Estimated Time: 2 hours 15 minutes Release Date: September 4, 2009 Type: Webcast |
Technical Requirements: Windows Media Expiration Date: September 4, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
Podcasts |
||
| Autoimmune and Inflammatory Disorders from Bench to Bedside | ||
| Estimated Time: 2 hours 15 minutes Release Date: November 6, 2009 Type: Webcast |
Technical Requirements: Quicktime with iTunes Expiration Date: November 6, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
| Biologics and Infections: Common and Rare | ||
| Estimated Time: 2 hours 30 minutes Release Date: November 6, 2009 Type: Webcast |
Technical Requirements: Quicktime with iTunes Expiration Date: November 6, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
| Biologic Therapies The Newer Agents | ||
| Estimated Time: 2 hours 30 minutes Release Date: November 6, 2009 Type: Webcast |
Technical Requirements: Quicktime with iTunes Expiration Date: November 6, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
| Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents | ||
| Estimated Time: 2 hours 15 minutes Release Date: November 6, 2009 Type: Webcast |
Technical Requirements: Quicktime with iTunes Expiration Date: November 6, 2011 Specialties: Rheumatology / Immunology, Cardiology |
|
Series Objectives
- Review and describe recent advances in basic immunology including B cell biology, cytokine biology, cell trafficking, and tolerance.
- Assess risks and mechanisms and prevention strategies for infectious complications attendant to biologic therapies.
- Describe the mechanisms of action, indications, and toxicity of newly approved agents as well as those in late development.
- Assess prevalence and risk of rare complications associated with agents in this class including hematologic, immunologic, cardiovascular, neurologic.
- Manage highly complex patient scenarios with biologics and compare their management decisions with global experts.
Target Audience
This Series is directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, internal medicine physicians, nurse practitioners, physician assistants, and other healthcare professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders.
Activity DirectorLeonard Calabrese, DO |
AccreditationThese activities have been approved for AMA PRA Category 1 Credit™ |
|
Planning CommitteeEdward Keystone, MD, FRCPC Elizabeth Kirchner, CNP Christopher T. Ritchlin, MD |
Nizar N. Zein, MD
|








